Chinese Medicine Meets Conventional Medicine in Targeting COVID-19 Pathophysiology, Complications and Comorbidities

OBJECTIVE: To investigate how the National Health Commission of China (NHCC)-recommended Chinese medicines (CMs) modulate the major maladjustments of coronavirus disease 2019 (COVID-19), particularly the clinically observed complications and comorbidities. METHODS: By focusing on the potent targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shan-shan, Zeng, Xian, Wang, Ya-li, Dongzhi, Zhuoma, Zhao, Yu-fen, Chen, Yu-zong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116066/
https://www.ncbi.nlm.nih.gov/pubmed/35583580
http://dx.doi.org/10.1007/s11655-022-3573-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116066/
https://www.ncbi.nlm.nih.gov/pubmed/35583580
http://dx.doi.org/10.1007/s11655-022-3573-0

Ejemplares similares